Single Nucleotide Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome

International Journal of Nephrology

Volumn 2016, Issue , 2016, Pages

  Suvanto, Maija ^a   Jahnukainen, Timo ^a   Kestilä, Marjo ^b   Jalanko, Hannu ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973312197     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2016/1417456     Document Type: Article

References (33)

1. L. C. Clement, C. Avila-Casado, C. Macé et al., "Podocytesecreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome, " Nature Medicine, vol. 17, no. 1, pp. 117-122, 2011.
2. L. C. Clement, C. Macé, C. Avila-Casado, J. A. Joles, S. Kersten, and S. S. Chugh, "Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome, " Nature Medicine, vol. 20, no. 1, pp. 37-46, 2014.
3. B. Acharya, T. Shirakawa, A. Pungky et al., "Polymorphism of the interleukin-4, interleukin-13, and signal transducer and activator of transcription 6 genes in Indonesian children with minimal change nephrotic syndrome, " American Journal of Nephrology, vol. 25, no. 1, pp. 30-35, 2005.
4. C.-L. Wei, W. Cheung, C.-K. Heng et al., "Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change disease, " Nephrology Dialysis Transplantation, vol. 20, no. 4, pp. 728-734, 2005.
5. A. Berdeli, S. Mir, N. Ozkayin, E. Serdaroglu, Y. Tabel, and A. Cura, "Association of macrophage migration inhibitory factor-173C allele polymorphism with steroid resistance in children with nephrotic syndrome, " Pediatric Nephrology, vol. 20, no. 11, pp. 1566-1571, 2005.
6. M. Vivarelli, L. E. D'Urbano, G. Stringini et al., "Association of the macrophage migration inhibitory factor-173c allele with childhood nephrotic syndrome, " Pediatric Nephrology, vol. 23, no. 5, pp. 743-748, 2008.
7. K. Okamoto, K. Tokunaga, K. Doi et al., "Common variation in GPC5 is associated with acquired nephrotic syndrome, " Nature Genetics, vol. 43, no. 5, pp. 459-463, 2011.
8. B. Alasehirli, A. Balat, O. Barlas, and A. Kont, "Nitric oxide synthase gene polymorphisms in children with minimal change nephrotic syndrome, " Pediatrics International, vol. 51, no. 1, pp. 75-78, 2009.
9. A. Wasilewska, G. Zalewski, L. Chyczewski, and W. Zoch-Zwierz, "MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children, " Pediatric Nephrology, vol. 22, no. 1, pp. 44-51, 2007.
10. S. Funaki, S. Takahashi, N. Wada, H. Murakami, and K. Harada, "Multiple drug-resistant gene 1 in children with steroid-sensitive nephrotic syndrome, " Pediatrics International, vol. 50, no. 2, pp. 159-161, 2008.
11. T. Jafar, N. Prasad, V. Agarwal et al., "MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children, "NephrologyDialysis Transplantation, vol. 26, no. 12, pp. 3968-3974, 2011.
12. D. M. Youssef, T. A. Attia, A. S. El-Shal, and F. A. Abduelometty, "Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids, " Gene, vol. 530, no. 2, pp. 201-207, 2013.
13. J. Ye, Z. Yu, J. Ding et al., "Genetic variations of theNR3C1 gene in children with sporadic nephrotic syndrome, " Biochemical and Biophysical Research Communications, vol. 348, no. 2, pp. 507-513, 2006.
14. N. Teeninga, J. E. Kist-van Holthe, E. L. T. van den Akker et al., "Genetic and in vivo determinants of glucocorticoid sensitivity in relation to clinical outcome of childhood nephrotic syndrome, " Kidney International, vol. 85, no. 6, pp. 1444-1453, 2014.
15. Y. Nishibori, K. Katayama, M. Parikka et al., "Glcci1 deficiency leads to proteinuria, " Journal of theAmerican Society of Nephrology, vol. 22, no. 11, pp. 2037-2046, 2011.
16. H. I. Cheong, H. G. Kang, and J. Schlondorff, "GLCCI1 single nucleotide polymorphisms in pediatric nephrotic syndrome, " Pediatric Nephrology, vol. 27, no. 9, pp. 1595-1599, 2012.
17. A.-T. Lahdenkari, M. Suvanto, E. Kajantie, O. Koskimies, M. Kestilä, and H. Jalanko, "Clinical features and outcome of childhood minimal change nephrotic syndrome: is genetics involved" Pediatric Nephrology, vol. 20, no. 8, pp. 1073-1080, 2005.
18. U. Lenkkeri, M. Männikkö, P. McCready et al., "Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization ofmutations, "TheAmerican Journal of Human Genetics, vol. 64, no. 1, pp. 51-61, 1999.
19. M. Stephens, N. J. Smith, and P. Donnelly, "A new statistical method for haplotype reconstruction from population data, " American Journal of Human Genetics, vol. 68, no. 4, pp. 978-989, 2001.
20. M. Stephens and P. Scheet, "Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation, " American Journal of Human Genetics, vol. 76, no. 3, pp. 449-462, 2005.
21. N. E. Buroker, X.-H. Ning, Z.-N. Zhou et al., "AKT3, ANGPTL4, eNOS3, and VEGFA associations with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan plateau, " International Journal of Hematology, vol. 96, no. 2, pp. 200-213, 2012.
22. H. J. Choi, H. Y. Cho, H. Ro et al., "Polymorphisms of theMDR1 andMIF genes in children with nephrotic syndrome, " Pediatric Nephrology, vol. 26, no. 11, pp. 1981-1988, 2011.
23. I. Fleury, P. Beaulieu, M. Primeau, D. Labuda, D. Sinnett, and M. Krajinovic, "Characterization of the BclI polymorphism in the glucocorticoid receptor gene, " Clinical Chemistry, vol. 49, no. 9, pp. 1528-1531, 2003.
24. K. Yoshida, T. Shimizugawa, M. Ono, and H. Furukawa, "Angiopoietin-like protein 4 is a potent hyperlipidemiainducing factor in mice and inhibitor of lipoprotein lipase, " Journal of Lipid Research, vol. 43, no. 11, pp. 1770-1772, 2002.
25. S. S. Chugh, L. C. Clement, and C. Macé, "New insights into human minimal change disease: lessons from animal models, " American Journal of Kidney Diseases, vol. 59, no. 2, pp. 284-292, 2012.
26. M. C. Smart-Halajko, M. R. Robciuc, J. A. Cooper et al., "The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 11, pp. 2277-2282, 2010.
27. R. B. Kim, B. F. Leake, E. F. Choo et al., "Identification of functionally variant MDR1 alleles among European Americans and African Americans, " Clinical Pharmacology and Therapeutics, vol. 70, no. 2, pp. 189-199, 2001.
28. D. Anglicheau, M. Flamant, M. H. Schlageter et al., "Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation, " Nephrology Dialysis Transplantation, vol. 18, no. 11, pp. 2409-2414, 2003.
29. M.-M. Ameyaw, F. Regateiro, T. Li et al., "MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity, " Pharmacogenetics, vol. 11, no. 3, pp. 217-221, 2001.
30. M. Cizmarikova, L. Podracka, L. Klimcakova et al., "MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results, " Medical Science Monitor, vol. 21, pp. 59S-68S, 2015.
31. E. F. C. van Rossum and S. W. J. Lamberts, "Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition, " Recent Progress in Hormone Research, vol. 59, pp. 333-357, 2004.
32. G. Zalewski, A. Wasilewska, W. Zoch-Zwierz, and L. Chyczewski, "Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome, " Pediatric Nephrology, vol. 23, no. 7, pp. 1073-1078, 2008.
33. K. G. Tantisira, J. Lasky-Su, M. Harada et al., "Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma, " The New England Journal of Medicine, vol. 365, no. 13, pp. 1173-1183, 2011.